Nerites Corporation Names Shaun Lonergan as Chief Executive Officer
“Since founding Nerites in 2004, I have looked forward to the day when the market validates our vision to the point that we can attract executives of Shaun’s caliber,” stated former CEO Thomas Mozer, who will continue to serve as President and Chief Operations Officer. “Our technology is maturing and we’ve made headway in product development. The Nerites team welcomes Shaun and we’re all very excited about the opportunities that his leadership will present.”
George Arida, Chairman of the Nerites Board of Directors, commented: “We’re extremely pleased to welcome Shaun Lonergan as Nerites’ new CEO. Shaun has broad and deep experience in commercializing new technologies and driving growth. Bringing Shaun on board will drive future partnerships and position us well for upcoming clinical trials and product commercialization.”
“Nerites has a solid foundation with an extremely innovative platform technology,” stated Lonergan. “They have attracted early partners and established a strong product pipeline. My goal in joining Nerites is to accelerate the commercial development process and broaden our set of corporate relationships. Many of the pieces are in place for an immensely successful medical device firm.”
About Nerites: Nerites Corporation commercializes, through partners, a new generation of synthetic bio-adhesives that can enhance natural tissue repair, reduce postoperative complications, and degrade safely when they are no longer needed. The hydrogel technology can be used to close internal tears or incisions, to prevent leakage and infection, and to affix synthetic or biologic medical devices. Properties can be “tuned” to fit each application. The technology was described with a cover article in the journal Nature (July, 2007) and was labeled “one of the top 100 scientific developments of 2007” by Discover Magazine. (www.Nerites.com)